Key Takeaway
- One of the key benefits of patient-centricity is that it enables pharma companies to carry less inventory.
TraceLink’s Roddy Martin explains how a patient-centric supply chain enables pharma companies to carry less inventory than they traditionally have in the past.
Transcript:
If we follow the model of thinking patient-centric and thinking back to the product supply network, it’s very logical that if we could at least segment patient demands or patients into communities of diseases, communities of therapies, geographic communities, we could start looking at groups of patients spread out in the patient-back supply chain.
Which means that as we distribute drugs and therapies into the supply chain, we don’t need to have hundreds of days of inventory.
We can have a lot less inventory at the right place at the right time because we have a very good idea where those therapies are needed for specific patient communities, to ensure that patients get what they require on time, in full.
Return to: The Patient-Driven Supply Network
